<DOC>
	<DOCNO>NCT02028312</DOCNO>
	<brief_summary>A pilot study evaluate impact Lotemax® Gel ( loteprednol etabonate ophthalmic gel 0.5 % ) initiation Restasis® ( cyclosporine ophthalmic emulsion 0.05 % ) therapy subject dry eye .</brief_summary>
	<brief_title>A Phase IV , Randomized , Parallel Group , Investigator-Masked Evaluation Effect Loteprednol Etabonate Ophthalmic Gel 0.5 % Initiation Dry Eye Treatment With Restasis®</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Loteprednol Etabonate</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>1 . Provide write informed consent prior studyrelated procedure provide Health Insurance Portability Accountability Act ( HIPAA ) authorization . 2 . Are age 21 80 inclusive . 3 . Have wear contact lens least 1 month prior study agrees wear contact lens study . 4 . Have stable oral medication 1 month prior study . 5 . Are generally good stable overall health . 6 . Are woman child bear potential ( WOCBP ) pregnant lactate sexually active ( i.e . abstinent ) Visit 1 willing remain Visit 4 . Alternatively , WOCBP abstinent must use acceptable method birth control least 4 week prior Visit 1 throughout study . 7 . Are woman undergone one follow sterilization procedure least 1 month prior Visit 1 : 1 . Bilateral tubal ligation 2 . Hysterectomy 3 . Hysterectomy unilateral bilateral oophorectomy . 4 . Bilateral oophorectomy 8 . Are likely comply eye drop regime , study guideline , study visit . 1 . Have history StevensJohnson Syndrome ocular pemphigoid . 2 . Have punctual plug insert remove ; punctual cautery 3 month prior Visit 1/Screening Baseline Visit throughout study . 3 . Have intraocular surgery within 6 month prior Visit 1/Screening Baseline Visit . 4 . Have history liver disease . 5 . Be pregnant lactating . 6 . Have severe clinical vitamin deficiency history vitamin overdose . 7 . Have highly variable vitamin intake . 8 . Wear contact lens . 9 . Have unstable use systemic topical medication know create dry eye . 10 . Have corneal pathology , could , , cause ocular surface disorder . 11 . Have use glaucoma medication , topical oral within 30 day Visit 1/Screening Baseline Visit . 12 . Have unstable diabetes mellitus . 13 . Have allergy sensitivity Lotemax® Gel , Restasis® , nonpreservative artificial tear . 14 . Have use topical steroid Restasis® within 1 month prior Screening Baseline Visit throughout study , except study medication provide per protocol . 15 . Have condition steroid use would contraindicate ( e.g . viral infection ) . 16 . Use topical ocular agent tear replacement within 1 week prior Screening Baseline Visit throughout study . 17 . Have expose investigational drug within precede 30 day . 18 . In opinion investigator study coordinator , unwilling unable comply study protocol unable successfully instill eye drop .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Dry Eye</keyword>
</DOC>